The Use of β-Blockers in Heart Failure with Reduced Ejection Fraction

Treatment with β-blockers is the main strategy for managing patients with heart failure and reduced ejection fraction because of their ability to reverse the neurohumoral effects of the sympathetic nervous system, with consequent prognostic and symptomatic benefits. However, to date, they are underu...

Descripción completa

Detalles Bibliográficos
Autores principales: Masarone, Daniele, Martucci, Maria Luigia, Errigo, Vittoria, Pacileo, Giuseppe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8468030/
https://www.ncbi.nlm.nih.gov/pubmed/34564119
http://dx.doi.org/10.3390/jcdd8090101

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8468030/
https://www.ncbi.nlm.nih.gov/pubmed/34564119
http://dx.doi.org/10.3390/jcdd8090101

Ejemplares similares